$BURU
Nuburu, Inc. Stock $buru

$buru Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000095017023041843 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$186.7K	$1.054M	$0.00
YoY Change
Cost Of Revenue	$1.116M	$2.485M	$1.267M
YoY Change	-39.03%	96.17%
Gross Profit	-$929.0K	-$1.431M	-$1.220M
YoY Change	-3.23%	17.36%
Gross Profit Margin	-497.45%	-135.78%
Selling, General & Admin	$2.859M	$3.390M	$1.691M
YoY Change	54.55%	100.56%
% of Gross Profit
Research & Development	$1.348M	$1.619M	$987.0K
YoY Change	26.02%	64.07%
% of Gross Profit
Depreciation & Amortization	$145.0K	$98.90K	$155.6K
YoY Change	61.06%	-36.45%
% of Gross Profit
Operating Expenses	$4.208M	$5.010M	$462.3K
YoY Change	461.11%	983.63%	-69.25%
Operating Profit	-$5.137M	-$6.441M	-$462.3K
YoY Change	585.0%	1293.2%	-69.25%
Interest Expense	$162.8K	$12.38K	$576.3K
YoY Change	-80.22%	-97.85%	4112.72%
% of Operating Profit
Other Income/Expense, Net	$167.1K	$334.2K	$2.425M
YoY Change	-87.63%	-86.22%	-127.87%
Pretax Income	-$5.085M	-$6.107M	$1.963M
YoY Change	-945.67%	-411.13%	-119.23%
Income Tax	$0.00	$0.00	$110.5K
% Of Pretax Income			5.63%
Net Earnings	-$5.085M	-$6.107M	$1.852M
YoY Change	-1258.37%	-429.7%	-118.15%
Net Earnings / Revenue	-2723.15%	-579.35%
Basic Earnings Per Share	-$0.14	-$0.18	-$0.71
Diluted Earnings Per Share	-$0.14	-$0.18	$44.34K
COMMON SHARES
Basic Shares Outstanding	35.41M	34.90M	5.525M
Diluted Shares Outstanding	35.43M	34.78M	5.525M

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.627M	$6.620M	$213.7K
YoY Change	323.05%	2998.38%	-85.44%
Cash & Equivalents	$1.627M	$6.625M	$213.7K
Short-Term Investments
Other Short-Term Assets	$13.27K	$7.813K	$32.08K
YoY Change	-88.47%	-75.65%	-82.7%
Inventory	$1.087M	$567.9K
Prepaid Expenses			$32.08K
Receivables	$469.9K	$646.9K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.828M	$8.592M	$245.7K
YoY Change	666.12%	3396.12%	-85.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.763M	$4.338M
YoY Change	4.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$335.2M
YoY Change			0.24%
Other Assets	$34.36K	$34.36K
YoY Change	14.53%
Total Long-Term Assets	$5.267M	$4.981M	$335.2M
YoY Change	-84.06%	-98.51%	0.24%
TOTAL ASSETS
Total Short-Term Assets	$3.828M	$8.592M	$245.7K
Total Long-Term Assets	$5.267M	$4.981M	$335.2M
Total Assets	$9.095M	$13.57M	$335.4M
YoY Change	-72.88%	-95.95%	-0.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.184M	$4.061M	$4.234M
YoY Change	-9.82%	-4.07%
Accrued Expenses	$1.670M	$1.585M	$109.0K
YoY Change		1353.8%	-97.11%
Deferred Revenue	$230.1K	$180.1K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.450M	$6.184M	$4.460M
YoY Change	31.13%	38.67%	18.19%
LONG-TERM LIABILITIES
Long-Term Debt	$6.713M	$6.710M	$0.00
YoY Change	1018.87%
Other Long-Term Liabilities	$429.6K	$690.0K	$14.34M
YoY Change	-96.89%	-95.19%	-69.72%
Total Long-Term Liabilities	$7.143M	$7.400M	$14.34M
YoY Change	-50.43%	-48.39%	-69.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.450M	$6.184M	$4.460M
Total Long-Term Liabilities	$7.143M	$7.400M	$14.34M
Total Liabilities	$13.59M	$13.59M	$18.80M
YoY Change	-29.68%	-27.71%	-63.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$77.15M	-$72.07M	-$18.02M
YoY Change	312.81%	299.97%	-13.47%
Common Stock	$3.555K	$3.529K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.498M	-$16.40K	-$18.02M
YoY Change
Total Liabilities & Shareholders Equity	$9.095M	$13.57M	$335.4M
YoY Change	-72.88%	-95.95%	-0.18%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$5.085M	-$6.107M	$1.852M
YoY Change	-1258.37%	-429.7%	-118.15%
Depreciation, Depletion And Amortization	$145.0K	$98.90K	$155.6K
YoY Change	61.06%	-36.45%
Cash From Operating Activities	-$4.559M	-$4.650M	-$111.8K
YoY Change	750.93%	4059.21%	-77.18%
INVESTING ACTIVITIES
Capital Expenditures	$312.9K	$490.0K	$90.00K
YoY Change	247.68%	444.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$312.9K	-$490.0K	-$90.00K
YoY Change	-100.1%	444.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-121.4K	10.23M	0.000
YoY Change	-99.96%
NET CHANGE
Cash From Operating Activities	-4.559M	-4.650M	-111.8K
Cash From Investing Activities	-312.9K	-490.0K	-90.00K
Cash From Financing Activities	-121.4K	10.23M	0.000
Net Change In Cash	-4.994M	5.090M	-111.8K
YoY Change	-3022.75%	-4652.77%	-77.18%
FREE CASH FLOW
Cash From Operating Activities	-$4.559M	-$4.650M	-$111.8K
Capital Expenditures	$312.9K	$490.0K	$90.00K
Free Cash Flow	-$4.872M	-$5.140M	-$201.8K
YoY Change	678.55%	2447.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001814215
	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39489
	dei	Entity Registrant Name EntityRegistrantName	NUBURU, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1288435
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7442 S Tucson Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 130
	dei	Entity Address City Or Town EntityAddressCityOrTown	Centennial
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	767-1400
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35412925
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6624736
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2880254
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	646935
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	327200
CY2023Q2	buru	Allowances For Inventory AllowancesForInventory	962388
CY2022Q4	buru	Allowances For Inventory AllowancesForInventory	292990
CY2023Q2	us-gaap	Inventory Net InventoryNet	567927
CY2022Q4	us-gaap	Inventory Net InventoryNet	972695
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	0
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	4258515
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	751977
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46737
CY2023Q2	us-gaap	Assets Current AssetsCurrent	8591575
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8485401
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4337662
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3771849
CY2023Q2	buru	Construction In Progress Noncurrent ConstructionInProgressNoncurrent	120051
CY2022Q4	buru	Construction In Progress Noncurrent ConstructionInProgressNoncurrent	188912
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	488513
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	641651
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34359
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34359
CY2023Q2	us-gaap	Assets Assets	13572160
CY2022Q4	us-gaap	Assets Assets	13122172
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4061495
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4456587
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1584640
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2312118
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	358266
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	343049
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	180075
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	178750
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	7300000
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6184476
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14590504
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	189518
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	373907
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	6713241
CY2023Q2	buru	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	501324
CY2022Q4	buru	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	0
CY2023Q2	us-gaap	Liabilities Liabilities	13588559
CY2022Q4	us-gaap	Liabilities Liabilities	14964411
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3038905
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3038905
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	23237703
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	23237703
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	304
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	12489
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3721
	us-gaap	Investment Income Interest InvestmentIncomeInterest	44916
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4303
CY2023Q2	us-gaap	Interest Expense InterestExpense	12384
CY2022Q2	us-gaap	Interest Expense InterestExpense	2214
	buru	Deferred Financing Costs Included In Accounts Payable And Accrued Expenses DeferredFinancingCostsIncludedInAccountsPayableAndAccruedExpenses	1245277
	buru	Transaction Costs Related To Reverse Recapitalization Not Yet Paid TransactionCostsRelatedToReverseRecapitalizationNotYetPaid	1007439
	buru	Convertible Promissory Notes And Warrants Issuance Costs ConvertiblePromissoryNotesAndWarrantsIssuanceCosts	160345
	buru	Issuance Of Common Stock Upon Conversion Of Preferred Stock In Connection With Reverse Recapitalization IssuanceOfCommonStockUponConversionOfPreferredStockInConnectionWithReverseRecapitalization	11575286
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	4040
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35288220
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35288220
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5556857
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5556857
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3529
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1077
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	72046305
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	59344952
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72066537
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61192308
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-16399
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1842239
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13572160
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13122172
CY2023Q2	us-gaap	Revenues Revenues	1054062
CY2022Q2	us-gaap	Revenues Revenues	47375
	us-gaap	Revenues Revenues	1524051
	us-gaap	Revenues Revenues	137375
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2485264
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1266892
	us-gaap	Cost Of Revenue CostOfRevenue	3697701
	us-gaap	Cost Of Revenue CostOfRevenue	1821944
CY2023Q2	us-gaap	Gross Profit GrossProfit	-1431202
CY2022Q2	us-gaap	Gross Profit GrossProfit	-1219517
	us-gaap	Gross Profit GrossProfit	-2173650
	us-gaap	Gross Profit GrossProfit	-1684569
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1619411
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	987032
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2951716
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1618533
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	366406
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	159179
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	542662
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	507959
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3024013
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1531330
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6074272
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2374373
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5009830
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2677541
	us-gaap	Operating Expenses OperatingExpenses	9568650
	us-gaap	Operating Expenses OperatingExpenses	4500865
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6441032
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3897058
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11742300
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6185434
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-16399
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9588075
	us-gaap	Interest Expense InterestExpense	12384
	us-gaap	Interest Expense InterestExpense	2214
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	334215
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	835539
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6106712
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3895551
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10874229
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6183345
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-6106712
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3895551
	us-gaap	Net Income Loss NetIncomeLoss	-10874229
	us-gaap	Net Income Loss NetIncomeLoss	-6183345
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.15
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34776044
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34776044
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5525140
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5525140
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30171187
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30171187
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5368105
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5368105
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1842239
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	11575286
CY2023Q1	buru	Issuance Of Common Stock And Preferred Stock Upon Reverse Recapitalization Net Of Issuance Costs IssuanceOfCommonStockAndPreferredStockUponReverseRecapitalizationNetOfIssuanceCosts	-3257525
CY2023Q1	buru	Recognition Of Public Warrants Upon The Reverse Recapitalization RecognitionOfPublicWarrantsUponTheReverseRecapitalization	-1336863
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	463978
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4767517
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	835120
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6999
CY2023Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2099997
CY2023Q2	buru	Issuance Cost From Issuance Of Common Stock Warrants IssuanceCostFromIssuanceOfCommonStockWarrants	160345
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2351414
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	796783
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-6106712
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	188890
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	107860
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	69455
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2287794
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7666486
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6066
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1197233
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3895551
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4974234
	us-gaap	Profit Loss ProfitLoss	-10874229
	us-gaap	Profit Loss ProfitLoss	-6183345
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	225016
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	290786
	us-gaap	Share Based Compensation ShareBasedCompensation	1260761
	us-gaap	Share Based Compensation ShareBasedCompensation	1266688
	buru	Changes In Fair Value Adjustment Of Warrants ChangesInFairValueAdjustmentOfWarrants	-835539
	buru	Excess And Obsolete Inventory Reserve Adjustments ExcessAndObsoleteInventoryReserveAdjustments	628069
	buru	Excess And Obsolete Inventory Reserve Adjustments ExcessAndObsoleteInventoryReserveAdjustments	51034
	buru	Inventory Lower Of Cost And Net Realizable Value Adjustment InventoryLowerOfCostAndNetRealizableValueAdjustment	41329
	buru	Inventory Lower Of Cost And Net Realizable Value Adjustment InventoryLowerOfCostAndNetRealizableValueAdjustment	218859
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	319735
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-72269
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	160726
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	603899
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	665240
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	65320
	buru	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-153138
	buru	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-144311
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2639014
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	165977
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-623819
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-80230
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1325
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	147501
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-169172
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-154901
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8699808
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4730270
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	825872
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	185472
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-825872
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-185472
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4100000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000
	buru	Proceeds From Issuance Of Convertible Promissory Notes And Warrants ProceedsFromIssuanceOfConvertiblePromissoryNotesAndWarrants	9225000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6999
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	113926
	buru	Proceeds From Issuance Of Preferred Stock ProceedsFromIssuanceOfPreferredStock	188890
	buru	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	3243079
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2099997
	buru	Payment Of Transaction Costs Related To Reverse Recapitalization PaymentOfTransactionCostsRelatedToReverseRecapitalization	4734913
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	675000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13270162
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	402816
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3744482
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4512926
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2880254
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6007575
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6624736
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1494649
	buru	Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	934583
	us-gaap	Net Income Loss NetIncomeLoss	-10874229
	us-gaap	Net Income Loss NetIncomeLoss	-6183345
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72066537
CY2023Q2	buru	Proceeds From Issuance Of Convertible Notes And Warrants ProceedsFromIssuanceOfConvertibleNotesAndWarrants	9225000
CY2023Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	11400000
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31323904
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31323904
	buru	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	3200000
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	779175
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1011421
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	420280
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	15213
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	330860
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	239051
CY2023Q2	us-gaap	Inventory Gross InventoryGross	1530315
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1265685
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	962388
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	292990
CY2023Q2	us-gaap	Inventory Net InventoryNet	567927
CY2022Q4	us-gaap	Inventory Net InventoryNet	972695
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	154491
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	218859
	us-gaap	Inventory Write Down InventoryWriteDown	385811
	us-gaap	Inventory Write Down InventoryWriteDown	218859
CY2023Q2	buru	Scrap Inventory Written Down ScrapInventoryWrittenDown	83832
CY2022Q2	buru	Scrap Inventory Written Down ScrapInventoryWrittenDown	0
	buru	Scrap Inventory Written Down ScrapInventoryWrittenDown	83832
	buru	Scrap Inventory Written Down ScrapInventoryWrittenDown	51034
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6849636
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5954903
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2511974
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2183054
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4337662
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3771849
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98901
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	155633
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	225016
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	290786
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47375
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	429392
CY2023Q2	buru	Prepaid Equipment PrepaidEquipment	198600
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	116172
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	34889
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	7813
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11848
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	751977
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46737
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	514375
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	636009
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	379914
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	548569
CY2023Q2	buru	Accrued Transaction Costs Related To Reverse Recapitalization Current AccruedTransactionCostsRelatedToReverseRecapitalizationCurrent	503600
CY2022Q4	buru	Accrued Transaction Costs Related To Reverse Recapitalization Current AccruedTransactionCostsRelatedToReverseRecapitalizationCurrent	651818
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	46746
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	108516
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	140005
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	367206
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1584640
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2312118
CY2023Q2	buru	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0
	buru	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1524051
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	85036
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	85036
	us-gaap	Operating Lease Cost OperatingLeaseCost	170073
	us-gaap	Operating Lease Cost OperatingLeaseCost	170073
	us-gaap	Operating Lease Payments OperatingLeasePayments	186107
	us-gaap	Operating Lease Payments OperatingLeasePayments	180662
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	934584
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	186107
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	383383
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	569490
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21706
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	547784
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	303182
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1054062
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47375
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1524051
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	137375
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	327200
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	178750
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	646935
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	180075
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1054062
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	137375
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	11400000
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	8.5
	buru	Convertible Preferred Stock Textblock ConvertiblePreferredStockTextblock	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">NOTE 9. CONVERTIBLE PREFERRED STOCK</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Legacy Nuburu Preferred Stock Financing</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">In multiple closings in December 2021 and January 2022, Legacy Nuburu sold an aggregate of </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1,166,372</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Legacy Nuburu Series C Preferred Stock, at a purchase price of $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">5.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> per share, for an aggregate purchase price of approximately $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">5.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Series A Preferred Stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Ranking</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company’s Preferred Stock ranks senior to the Company’s Common Stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Dividends</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Holders of the Company’s Preferred Stock participate, on an as-converted basis (without regard to any conversion limitations) in all dividends paid to the holders of the Company’s Common Stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Conversion Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Preferred Stock is convertible at any time into Common Stock at a conversion rate equal to $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> (subject to equitable adjustment in the event of a stock split, stock consolidation, subdivision or certain other events of a similar nature that increase or decrease the number of shares of Preferred Stock outstanding (the “Original Issuance Price”)) divided by the lesser of (i) $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">11.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> and (ii) the greater of (x) </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">115</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of the lowest volume-weighted average price per share of the Company’s Common Stock as displayed under the heading Bloomberg VWAP (the “VWAP”) for any consecutive ninety-trading day period prior to the calculation of such VWAP and (y) $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">5.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">, in each case subject to adjustment as set forth in the Certificate of Designations (the “Conversion Price”).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Any conversion will be settled only in shares of Common Stock; provided, that, upon any conversion that would result in the holders beneficially owning greater than </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">9.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of the Company’s voting stock outstanding as of the conversion date or any individual holder beneficially owning Common Stock in excess of the maximum number of shares of Common Stock that could be issued to the holder without triggering a change of control under the applicable stock exchange listing rules, the excess, if any, of the conversion consideration otherwise payable upon such conversion shall be paid in cash, based on an amount per share of Common Stock equal to the last reported price per share of the Common Stock on the trading day immediately preceding the conversion date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Mandatory Conversion</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">If the VWAP is greater than </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">200</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of the Conversion Price for any </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> trading days in a </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">30-day</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> trading day period, the Company may elect to convert all, but not less than all, of the Preferred Stock then outstanding into the Company’s Common Stock at a conversion rate with respect to each share of Preferred Stock equal to the Original Issuance Price as of the date of such conversion divided by the then applicable Conversion Price.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Voting Rights</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The holders of Preferred Stock are not entitled to vote at or receive notice of any meeting of stockholders, except the holders of Preferred Stock are entitled to certain consent rights on matters related to (i) the creation or authorization of the creation of any equity or debt securities of the Company that rank senior or equal to certain rights of the Preferred Stock and (ii) the authorization of any adverse change to the powers, preferences, or special rights of the Preferred Stock set forth in the Company’s Certificate of Incorporation or Bylaws, and shall have voting rights as required by law.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Redemption</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">On the second anniversary of the Closing Date, or January 31, 2025 (the “Test Date”), the Company is obligated to redeem the maximum portion of the Preferred Stock permitted by law in cash at an amount equal to the Original Issuance Price as of such date if the Conversion Price exceeds the VWAP. If, on the Test Date, the Conversion Price is equal to or less than the VWAP, the Company must convert all shares of Preferred Stock then outstanding into shares of the Company’s Common Stock at the then applicable Conversion Price. Notwithstanding the foregoing, the Company shall not be required to redeem any shares of Preferred Stock to the extent the Company does not have legally available funds to effect such redemption. The mandatory redemption and conversion provisions described herein are further subject to certain limitations detailed in the Certificate of Designations.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Series A Preferred Stock Issuances</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company is authorized to issue </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">50,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of preferred stock with a par value of $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2023 and December 31, 2022, there were </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">3,038,905</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> and </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">23,237,703</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of preferred stock issued or outstanding, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Upon the Closing of the Business Combination, all </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">23,237,703</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of issued and outstanding convertible preferred stock were cancelled and converted into </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">23,237,703</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Legacy Nuburu common stock based upon the conversion rate as calculated pursuant to Legacy Nuburu's Certificate of Incorporation, multiplied by the Exchange Ratios at the Effective Time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Additionally, upon the Closing of the Business Combination, the cancellation and conversion of all Legacy Nuburu Company Notes into shares of Legacy Nuburu common stock in accordance with its terms as of immediately prior to the Effective Time resulted in the issuance of </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2,642,239</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares which were then outstanding as Legacy Nuburu common stock as of immediately prior to the Effective Time and subsequently converted into </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1,361,787</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Nuburu Common Stock and </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1,361,787</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Nuburu Series A preferred stock at the Effective Time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">As of the Closing, each Legacy Nuburu stockholder waived its right to participate in the Preferred Stock Issuance (for clarity, excluding any shares received as a result of the conversion of any Legacy Company Notes prior to the Closing, which were entitled to participate in the Preferred Stock Issuance). Legacy Nuburu stockholders were entitled to receive approximately </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of the Common Stock issued as merger consideration pursuant to the Business Combination Agreement agreed to waive such right by entering into the Stockholder Support Agreement (for clarity, excluding any shares received as a result of the conversion of any Legacy Company Notes). Those Legacy Nuburu stockholders who did not waive their right to participate resulted in the issuance of </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">15,478</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Nuburu Series A preferred stock at the Effective Time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Each Tailwind stockholder who did not redeem their shares received a share of Nuburu Series A preferred stock. This resulted in the issuance of </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">316,188</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Nuburu Series A preferred stock to those non-redeeming stockholders.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Tailwind and the Tailwind Sponsor entered into the Sponsor Support and Forfeiture Agreement. In connection with the Business Combination, the </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">8,355,393</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> Founder Shares were forfeited other than </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1,150,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Common Stock (of which, </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">150,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares were transferred to Nautilus Maser Fund, L.P. and </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">50,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares were transferred to Cohen & Company Capital Markets at Closing) and </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">650,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Series A preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Wilson Sonsini Goodrich & Rosati, Professional Corporation (“WSGR”) was engaged by Legacy Nuburu to act as its counsel for the Business Combination. As partial compensation for the services provided by WSGR to Legacy Nuburu in connection with the Business Combination, the Company agreed to issue to WSGR </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">195,452</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Common Stock and </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">195,452</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Preferred Stock pursuant to the terms of the Stock Purchase Agreement entered into by and between the Company and WSGR on March 10, 2023. The foregoing issuance was made in a transaction not involving a public offering pursuant to an exemption from the registration requirements of the Securities Act in reliance upon Section 4(a)(2) of the Securities Act or Regulation D promulgated under the Securities Act.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Legacy Nuburu entered into an engagement letter with Anzu Partners on August 30, 2022 pursuant to which Legacy Nuburu, in recognition of past Services, (i) agreed to pay $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> to Anzu Partners upon the closing of the Business Combination and (ii) issued a warrant with a strike price of $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">0.01</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> per share to Anzu Partners for </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> shares of Preferred Stock (the “Anzu Partners Warrant”). This warrant was exercised by Anzu Partners in connection with the Closing and the $</span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> payment was made during the three months ended June 30, 2023.</span></p>
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	11518895
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1889535
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2023Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2028-06-23
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9225000
	buru	Fair Value Of Warrants FairValueOfWarrants	3401366
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2511759
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	796782
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1197233
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1260761
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1266688
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3133270
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.35
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5484316
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	115000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.49
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5153
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	36072
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.98
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3207045
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.31
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	241144
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2006246
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M24D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	217877
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3207045
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.31
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y6M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	241144
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.467
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.034
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.022
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	buru	Minimum Percentage Increase In Ownership By Five Percent Shareholders During A Three Year Testing Period MinimumPercentageIncreaseInOwnershipByFivePercentShareholdersDuringAThreeYearTestingPeriod	0.50
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53768210
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4887484

Files In Submission

Name	View Source	Status
0000950170-23-041843-index-headers.html	Edgar Link	pending
0000950170-23-041843-index.html	Edgar Link	pending
0000950170-23-041843.txt	Edgar Link	pending
0000950170-23-041843-xbrl.zip	Edgar Link	pending
buru-20230630.htm	Edgar Link	pending
buru-20230630.xsd	Edgar Link	pending
buru-ex31_1.htm	Edgar Link	pending
buru-20230630_cal.xml	Edgar Link	unprocessable
buru-20230630_def.xml	Edgar Link	unprocessable
buru-20230630_lab.xml	Edgar Link	unprocessable
buru-20230630_pre.xml	Edgar Link	unprocessable
buru-20230630_htm.xml	Edgar Link	completed
buru-ex31_2.htm	Edgar Link	pending
buru-ex32_1.htm	Edgar Link	pending
buru-ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BURU
Nuburu, Inc. Stock $buru

2023 Q3 Form 10-Q Financial Statement

#000095017023041843 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BURU Nuburu, Inc. Stock $buru

2023 Q3 Form 10-Q Financial Statement

#000095017023041843 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BURU
Nuburu, Inc. Stock $buru